Stay updated on Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-06T17:46:51.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; this is a minor system-level update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:50:42.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Minor site revision from v3.4.0 to v3.4.1 with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:14:13.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous Revision: v3.3.3 on the page.
    Difference
    0.1%
    Check dated 2026-01-15T04:25:35.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added New York and Oregon locations in the Locations section and updated the page revision to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-24T10:49:44.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; there are no changes to the study details, eligibility criteria, outcomes, or other user-facing content.
    Difference
    0.1%
    Check dated 2025-12-01T15:53:23.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.